Tower Research Capital (TRC)’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,466
Closed -$13K 5828
2024
Q1
$13K Buy
8,466
+2,545
+43% +$4.16K ﹤0.01% 3424
2023
Q4
$9.65K Sell
5,921
-2,101
-26% -$3.6K ﹤0.01% 4361
2023
Q3
$23.9K Buy
8,022
+6,143
+327% +$23.4K ﹤0.01% 3209
2023
Q2
$8.38K Sell
1,879
-2,767
-60% -$12.4K ﹤0.01% 4438
2023
Q1
$9K Buy
4,646
+2,608
+128% +$5.63K ﹤0.01% 4498
2022
Q4
$6K Sell
2,038
-605
-23% -$1.54K ﹤0.01% 4723
2022
Q3
$7K Sell
2,643
-1,121
-30% -$2.52K ﹤0.01% 4890
2022
Q2
$5K Buy
+3,764
New +$5.72K ﹤0.01% 5056
2022
Q1
Sell
-231
Closed -$1K 6295
2021
Q4
$1K Buy
+231
New +$929 ﹤0.01% 5833
2021
Q1
Sell
-4,590
Closed -$23K 5534
2020
Q4
$23K Buy
4,590
+2,638
+135% +$11.9K ﹤0.01% 3774
2020
Q3
$9K Sell
1,952
-124
-6% -$571 ﹤0.01% 4137
2020
Q2
$10K Buy
2,076
+1,813
+689% +$11.8K ﹤0.01% 4011
2020
Q1
$1K Sell
263
-9,912
-97% -$36.7K ﹤0.01% 2785
2019
Q4
$41K Buy
10,175
+8,714
+596% +$25.5K ﹤0.01% 1464
2019
Q3
$4K Sell
1,461
-1,637
-53% -$4.76K ﹤0.01% 3418
2019
Q2
$10K Buy
3,098
+2,244
+263% +$71K ﹤0.01% 2561
2019
Q1
$32K Buy
854
+257
+43% +$9.57K ﹤0.01% 1995
2018
Q4
$22K Sell
597
-3,308
-85% -$102K ﹤0.01% 1869
2018
Q3
$134K Buy
3,905
+1,048
+37% +$33.8K 0.01% 1188
2018
Q2
$92K Buy
2,857
+333
+13% +$11.5K 0.01% 1487
2018
Q1
$73K Buy
2,524
+2,147
+569% +$56.6K 0.01% 1456
2017
Q4
$8K Buy
+377
New +$6.8K ﹤0.01% 2666

Other funds holding IFRX

Tower Research Capital (TRC)'s IFRX Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of InflaRx (IFRX) in Q2 2024, closing a stake of 8,466 shares — an estimated $13K sold.

Tower Research Capital (TRC) first reported a position in IFRX in Q4 2017 and held it in 22 quarters. The position peaked at $134K in Q3 2018. 33 funds tracked by Wall St. Rank hold IFRX as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining InflaRx position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 8,466 InflaRx shares in Q2 2024, an estimated $13K.
  • Tower Research Capital (TRC) first reported a position in InflaRx in Q4 2017 and held it in 22 quarters.
  • Tower Research Capital (TRC)'s InflaRx position peaked at $134K in Q3 2018.
  • 33 funds tracked by Wall St. Rank held InflaRx as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.